Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.30
Bid: 8.20
Ask: 8.40
Change: -0.10 (-1.19%)
Spread: 0.20 (2.439%)
Open: 8.40
High: 8.35
Low: 8.30
Prev. Close: 8.40
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value calculation to 30 September 2021

5 Nov 2021 07:00

RNS Number : 4172R
Agronomics Limited
05 November 2021
 

5th November 2021

Agronomics Limited

("Agronomics" or the "Company")

Net Asset Value calculation to 30 September 2021

Agronomics Limited (AIM:ANIC), the leading listed company focused on the field of cellular agriculture, announces that the unaudited Net Asset Valuation ("NAV") calculation as at closing on 30 September 2021 was 12.99 pence per share, including un-invested cash of £55.1 million. Net Assets stand at £103.9 million, including investments of £50.5 million. This quarter's NAV per share represents an increase of 10.93% from the previous quarter's NAV of 11.71 pence per share.

The share price of 27.5 pence at the 30 September 2021 close represents a premium of 111.7% to the NAV per share. Under IFRS, the Company's unquoted investments are carried at cost or the most recent priced funding round.

Richard Reed, Chairman of Agronomics, commented: -

"Our assets have continued to perform well and the broader developments across our holdings in the period have further strengthened our position as the largest listed company focused on the field of cellular agriculture. Large and well-known institutional investors have begun investing in our portfolio companies, with this being a positive for both the Company and the wider industry as a whole.

We continue to believe that there is significant intrinsic value not yet reflected in our financial accounts which will be recognised as our portfolio companies complete further priced funding rounds."

During July 2021, BlueNalu, Inc, a leading innovative food company producing a variety of seafood products directly from fish cells, and CellX Limited, a China-based cellular agriculture company, reached the Semi-Finals of XPRIZE's 'Feed the Next Billion' competition, with the US $15 million competition being aimed at reinventing how humanity will feed future generations by incentivising the production of structured chicken breast or fish fillet alternatives that replicate or outperform conventional chicken and fish in access, environmental sustainability, animal welfare, nutrition and health, as well as taste and texture.

On 16 July 2021, warrants issued by the Company as part of the May 2021 fundraise commenced trading on the JP Jenkins trade desk.

On 21 July 2021, Shiok Meats Pte. Ltd. ("Shiok Meats"), the leading cell-based crustacean meat company, completed a bridge funding round from South Korean strategic investors Woowa Brothers Asia Holdings and CJ CheilJedang Corporation, as well as Vietnamese seafood exporter Vinh Hoan Corporation. No material adjustments were made to the carrying value of the Shiok Meats investment.

On 13 September 2021, Formo Bio GmbH (previously named LegenDairy), Europe's first cellular agriculture company developing cultivated dairy products, completed a US $50 million Series A funding round, with Agronomics acquiring 1,191 Series A Preferred Shares for a €3.15 million investment. Agronomics now holds a total of 4,030 shares in Formo, representing an equity ownership of 5.94% on a fully diluted basis. Completion of the Series A funding round resulted in a 7.5x uplift on the original investment, an IRR of 225%, and an unrealised gain of £5.6 million.

On 20 September 2021, Agronomics announced that it led the Series A funding round of VitroLabs Inc ("VitroLabs"), a biotechnology company focused on producing leather via its innovative and unique cell culture process, with a US $7 million investment. The existing SAFE and CLN investments, which totaled US $3.5 million, converted into Series A shares on completion. The uplift resulted in an unrealised gain of US $2.25 million and an IRR of 40%.

On 22 September 2021, Mosa Meat B.V. ("Mosa Meat"), a global food technology company pioneering a cleaner, kinder way of making real beef, announced that it secured funding from Leonardo DiCaprio, who will now act as an advisor to Mosa Meat.

On 28 September 2021, Simply Foods, Inc., trading as New Age Meats, a cultivated and plant-based meat startup in Berkeley, CA with an initial focus on pork, closed a US $25 million Series A funding round led by Hanwha Solutions Corporation, a South Korean conglomerate. The Series A financing represents a 5.14x uplift on the original cash investment by Agronomics, with an IRR of 119%, including an unrealised gain on cost of US $2.90 million.

On 29 September 2021, Agronomics disposed of its total holding of 40,000 shares in Oritain Global Limited for NZ $1.36 million (approximately £0.7 million), representing an IRR of 74%.

 

Unaudited to

30 September 2021

£

Fixed Assets

Investments

50,476,414

Current Assets

Uninvested Cash

55,062,325

Sundry Debtors

53,068

Current Liabilities

Trade and Other Creditors

(103,039)

Future investment commitment

(1,592,178)

Net Assets

103,896,590

Capital and Reserves

Share Capital

799

Share Premium

91,458,482

Retained Earnings

12,437,309

Net assets

103,896,590

Shares in Issue

799,606,383

Net Asset Value per share

12.99 pence

 

The quoted investments within the portfolio are valued under IFRS at bid price.

Portfolio Details

Investments as at 30 September 2021

Value (£)

% of Total Portfolio

Quoted holdings

656,206

1.30%

Unquoted holdings

48,228,030

95.55%

Committed future investment

1,592,178

3.15%

Total

50,476,414

100%

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

For further information please contact:

Agronomics

Limited

Beaumont

Cornish Limited

Cenkos

Securities Plc

Peterhouse Capital

Limited

TB Cardew

The Company

Nomad

Joint Broker

Joint Broker

Public Relations

Richard Reed

Denham Eke

Roland Cornish

James Biddle

Giles Balleny

Michael Johnson

Lucy Williams

Charles Goodfellow

Ed Orlebar

Joe McGregor

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 397 8900

+44 (0) 207 469 0936

+44 (0) 20 7930 0777

+44 (0) 7738 724 630

agronomics@tbcardew.com

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBLBDBUSGDGBS
Date   Source Headline
12th Oct 20167:00 amRNSNet Asset Value(s)
22nd Jul 20167:00 amRNSNet Asset Value(s)
29th Apr 20167:00 amRNSNet Asset Value calculation to 31 March 2016
15th Apr 20167:00 amRNSChange of Adviser
18th Mar 20167:00 amRNSHolding(s) in Company
17th Mar 20167:00 amRNSInterim Results for the six months to 31 Dec 2015
10th Feb 201612:11 pmRNSResult of AGM
25th Jan 20167:00 amRNSNet Asset Value(s)
22nd Dec 20157:00 amRNSAnnual Audited Results and Notice of AGM
17th Dec 20154:00 pmRNSDBC receives US FDA approval to market PulseFlowDF
4th Nov 20157:00 amRNSNet Asset Value(s)
30th Jul 20157:01 amRNSNet Asset Value(s)
15th Apr 20157:00 amRNSNet Asset Value as at 31 March 2015
30th Mar 20157:00 amRNSInterim results for 6 months to 31 December 2014
6th Feb 201512:21 pmRNSClose of Tender Offer
4th Feb 20155:36 pmRNSRe Results of Tender Offer
2nd Feb 20158:00 amRNSResults of Tender Offer
23rd Jan 20157:00 amRNSHolding(s) in Company
15th Jan 201511:56 amRNSHolding(s) in Company
14th Jan 20157:00 amRNSTender Offer
12th Jan 20159:32 amRNSNet Asset Value
30th Dec 20147:00 amRNSAnnual audited results
23rd Dec 201411:58 amRNSHolding(s) in Company
28th Nov 20142:04 pmRNSTender Offer in respect of Magna Biopharma
21st Oct 20147:00 amRNSNet Asset Value to 30 September 2014
22nd Jul 20147:00 amRNSNet Asset Value(s)
8th Apr 20147:00 amRNSNet Asset Value calculations to 31 March 2014
31st Mar 20147:00 amRNSInterim Results for the six months to 31 Dec 2013
24th Jan 201411:21 amRNSHolding(s) in Company
20th Jan 201410:56 amRNSHolding(s) in Company
17th Jan 20147:00 amRNSNet Asset Value(s)
15th Jan 20147:00 amRNSAppointment of Nominated Adviser
6th Jan 20145:49 pmRNSHolding(s) in Company
20th Nov 20134:04 pmRNSHolding(s) in Company
13th Nov 20135:13 pmRNSHolding(s) in Company
12th Nov 20137:00 amRNSResult of General Meeting
24th Oct 20137:01 amRNSNotice of General Meeting
24th Oct 20137:00 amRNSAnnual Financial Report
18th Oct 201311:23 amRNSHolding(s) in Company
18th Oct 20137:00 amRNSNet Asset Value(s)
4th Oct 20132:13 pmRNSHolding(s) in Company
26th Sep 20135:10 pmRNSHolding(s) in Company
13th Sep 201311:32 amRNSHolding(s) in Company
6th Sep 20135:29 pmRNSHolding(s) in Company
6th Aug 20139:40 amRNSHolding(s) in Company
11th Jul 20137:00 amRNSNet Asset Value(s)
15th Apr 201312:34 pmRNSDirectorate Change
12th Apr 20132:17 pmRNSHolding(s) in Company
10th Apr 20137:00 amRNSDirector/PDMR Shareholding
9th Apr 20137:00 amRNSNet Asset Value calculation to 31st March 2013

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.